TAG:
clinical lab testing
Oncology Diagnostics Attracts Big Money
MORE SURPRISING DEVELOPMENTS for the anatomic pathology profession during the past three weeks! The impending $215 million acquisition of IMPATH, Inc. by Genzyme Corporation, announced on March 1, has the …
LabCorp Starts Tinkering With DIANON Systems
CEO SUMMARY: For almost two decades, DIANON Systems supported one of the most successful sales and marketing programs in the public laboratory sector. However, despite its pre-acquisition statements that it would retain DIANON’s operational integrity, LabCorp has already begun to implem…
Why DIANON Sale Alters Anatomic Path Market
CEO SUMMARY: By acquiring DIANON Systems, LabCorp raises the level of competition for tissue specimens originating in physicians’ offices. LabCorp’s acquisition is also a validation of predictions that cancer diagnostics will be a high-growth segment of laboratory medicine. Anatomic p…
“November 18, 2002 Intelligence: Late Breaking Lab News”
Antitrust regulators are signaling displeasure about a growing number of business activities in healthcare. Timothy Muris, Chairman of the Federal Trade Commission (FTC), was in Chicago on November 7 to address a group of lawyers and business people. He told them that the FTC “cont…
United Kingdom Soon to Tackle Consolidation of Hospital Labs
CEO SUMMARY: Consolidation and regionalization of hospital laboratory testing are not isolated phenomenons. Beginning in the late 1980s, individual provinces in Canada began to rationalize lab testing services by building core labs and consolidating lab services across multiple hospitals….
Terrorist Attacks Affect Many of Nation’s Labs
CEO SUMMARY: Following terrorist attacks in New York City and Washington, DC, the total shutdown of commercial air traffic in the United States for 48 hours disrupted the regular shipment of reference and esoteric lab specimens to national laboratories. Swiftly-implemented contingency eff…
Anatomic Pathology May Be “Hot” Opportunity
EVERY NOW AND THEN, IT HELPS TO STAND BACK and look at the big picture. In this issue, you will read a unique…
DIANON Acquires UroCor And Boosts Urology Share
CEO SUMMARY: Following years of intense competition for the diagnostic testing business of office-based urologists, DIANON Systems and UroCor will now join forces. The recently-announced merger creates a powerhouse anatomic pathology company in the urology-based diagnostics services marke…
Analysis of Lab Testing Market Reveals Competitive Shifts
CEO SUMMARY: Even as public lab and anatomic pathology companies enjoy sustained growth in specimen volumes and revenues, fundamental shifts in the basic marketplace have changed the competitive environment. Surprisingly, the most open market segment is anatomic pathology specimens referr…
Patients “Bypassing” Doctors To Order Tests From Labs
FOR THE SECOND TIME IN eight weeks, the Wall Street Journal (WSJ) has a printed a prominent story about trends in laboratory testing. Last Friday, June 8, 2001, the WSJ’s “Health Journal” column featured a story entitled “Patients Bypass Doctors to Get Medical Tests Directly From La…
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.